Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In this paper we summarize and discuss the problem of the antibiotic resistance issue and potential intervention strategies in low- and middle-income countries (LMILs). In Europe and North America surveillance data are available and research networks are active, however, these are still largely lacking in LMILs. In recent years some initiatives have been set up for LMIL, such as 'Action on Antibiotic Resistance' (ReACT) and the 'Global Antibiotic Resistance Partnership' (GARP). While better data on antibiotic resistance and its causes in LMILs are needed, there is a more urgent need for affordable interventions to turn the tide. Unlike programs aimed at combatting bacterial antibiotic resistance, there are already strong global programs to tackle resistance in HIV/AIDS, tuberculosis and malaria. We should learn from these programs to improve efforts to control and treat resistant bacterial infections.

Type

Journal article

Journal

Ned Tijdschr Geneeskd

Publication Date

2014

Volume

158

Keywords

Anti-Bacterial Agents, Bacterial Infections, Developing Countries, Drug Resistance, Bacterial, Humans